Rigel Pharmaceuticals
RIGL
RIGL
135 hedge funds and large institutions have $157M invested in Rigel Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 51 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-28
Holders Change %
-17.18%
% of All Funds
2.28%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
35
Reduced
51
Closed
34
Calls
$1.19M
Puts
$584K
Net Calls
+$604K
Net Calls Change
+$7K
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$27.1M |
| 2 |
2
D.E. Shaw & Co
New York
|
$3.93M |
| 3 |
SFM
3
Sphera Funds Management
Tel Aviv,
Israel
|
$2.85M |
| 4 |
4
Citigroup
New York
|
$1.78M |
| 5 |
5
Acadian Asset Management
Boston,
Massachusetts
|
$2.51M |
